Towards the development of a personalised E-Health intervention for use in community pharmacies to analyse and improve medication non-adherence in people with type 2 diabetes mellitus, who are non-adherent to oral blood glucose and blood pressure lowering drugs

niversity of East Anglia0 个研究点目标入组 23 人开始时间: 2020年2月5日最近更新: 2022年9月19日

适应症

试验速览

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36056388/ (added 05/09/2022)

•1. People with T2DM prescribed oral blood glucose lowering medication that are non-adherent to oral blood glucose and/or blood pressure lowering drugs
•2. Aged 35-75 years
•3. Smartphone user and willing to use platform facilities (digital health resources) or have access to an electronic device (e.g. computer)
•4. All ethnicities
•5. Able to understand text messages in English

•1. People with T2DM that use parenteral medication (e.g. insulin) for diabetes
•2. People in which, according to screening data collected, adherence data is not valid due to hospital admission or in which medication is dispensed by different pharmacies
•3. People who use medication-intake supporting services provided by the pharmacy (i.e. repeat dispensing and pill packaging)
•4. People who indicate in the questionnaire that they suffer from the following major mental health disorders: depression, schizophrenia, psychosis or suicidality
•5. Any significant medical reason for exclusion as determined by the researchers
•6. Unable or not willing to provide written informed consent
•7. Not willing to accept information transfer concerning participation in the study, and/or information regarding a participants’ health (like laboratory results or physical examination) and/or eventual adverse events to and from his GP and/or pharmacist
•8. People who are involved in current research or have recently been involved in any research prior to recruitment

发起方

niversity of East Anglia